Association of SMAD4 loss with drug resistance in clinical cancer patients: A systematic meta-analysis.

Xu, Wei; Lee, Sau Har; Qiu, Fengjun; Zhou, Li; Wang, Xiaoling; Ye, Tingjie; Hu, Xudong

Xu, Wei; Lee, Sau Har; Qiu, Fengjun; Zhou, Li; Wang, Xiaoling; Ye, Tingjie; Hu, Xudong.

Afiliação

Xu W; School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Lee SH; School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Selangor, Malaysia.
Qiu F; School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhou L; iSoftStone Information Technology (Group) Co., Ltd, Beijing, China.
Wang X; School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Ye T; School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Hu X; School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

PLoS One ; 16(5): e0250634, 2021.

Article em En | MEDLINE | ID: mdl-34048444

Assuntos

Biomarcadores Tumorais/metabolismo; Resistencia a Medicamentos Antineoplásicos; Neoplasias/patologia; Proteína Smad4/metabolismo; Humanos; Metástase Neoplásica; Neoplasias/genética; Neoplasias/metabolismo; Prognóstico; Proteína Smad4/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Proteína Smad4 / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google